Matches in Wikidata for { <http://www.wikidata.org/entity/Q64723604> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q64723604 description "clinical trial" @default.
- Q64723604 description "ensayu clínicu" @default.
- Q64723604 description "klinisch onderzoek" @default.
- Q64723604 description "клінічне випробування" @default.
- Q64723604 description "կլինիկական փորձարկում" @default.
- Q64723604 name "Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes" @default.
- Q64723604 type Item @default.
- Q64723604 label "Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes" @default.
- Q64723604 prefLabel "Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes" @default.
- Q64723604 P1050 Q64723604-99FF412D-3079-4672-BB49-128546F47326 @default.
- Q64723604 P1132 Q64723604-BC2B130C-F461-401A-84CD-6961BFE95B55 @default.
- Q64723604 P1476 Q64723604-DC685040-CBAE-4F2D-BEF1-ABC8E51E3ADE @default.
- Q64723604 P17 Q64723604-030B645C-D9AA-4FDE-963B-FE2D4002D58F @default.
- Q64723604 P17 Q64723604-0F050814-E427-48E1-A043-75A1671F150C @default.
- Q64723604 P17 Q64723604-677312F5-CEE4-47CB-B84F-D12E1496989C @default.
- Q64723604 P17 Q64723604-948CE2C4-B48E-44E9-A05F-BE8ED7D1303D @default.
- Q64723604 P17 Q64723604-9C33721C-E535-4DA9-A231-47A1C8F97A6F @default.
- Q64723604 P17 Q64723604-C003366D-8ADC-4227-ACFD-34C97DD95AD6 @default.
- Q64723604 P17 Q64723604-E38D41F7-9576-4B96-A967-4932E0231CA7 @default.
- Q64723604 P17 Q64723604-E3C9BEAB-8941-474A-8740-D9A56954A010 @default.
- Q64723604 P17 Q64723604-F9979032-D716-4E78-B3A1-317B0AB6475D @default.
- Q64723604 P2899 Q64723604-66F2BE47-7389-47F4-B861-26BBE80951EC @default.
- Q64723604 P3098 Q64723604-3BC0B8B3-C617-47EF-9588-C5326DF8E836 @default.
- Q64723604 P31 Q64723604-D8CB9F64-CE53-49D7-97D8-30442E7B0154 @default.
- Q64723604 P4135 Q64723604-05853D38-FCF2-4732-8467-21E757BFA85A @default.
- Q64723604 P4844 Q64723604-294A6452-12AD-4B5F-8344-A29EFC1C6D0D @default.
- Q64723604 P4844 Q64723604-CB0B0417-5654-44C9-90FF-71CAC7EEBBB6 @default.
- Q64723604 P580 Q64723604-42941120-E6DE-4038-8154-EC2C49B8E4E4 @default.
- Q64723604 P582 Q64723604-BFFAAEEC-427D-4E57-B008-C6E569C2E066 @default.
- Q64723604 P6099 Q64723604-B2B6FF0F-40FE-418B-93DE-1724FCC6F3C4 @default.
- Q64723604 P8363 Q64723604-517AB318-16D5-4923-81DF-0863D1AE760B @default.
- Q64723604 P1050 Q12206 @default.
- Q64723604 P1132 "+701" @default.
- Q64723604 P1476 "A Randomised, Double-blind, Placebo-controlled Parallel Group Efficacy and Safety Study of BI 1356 (One Dose, e.g. 5 mg), Administered Orally Once Daily Over 24 Weeks, With an Open Label Extension to 80 Weeks (Placebo Patients Switched to BI 1356), in Type 2 Diabetic Patients With Insufficient Glycaemic Control Despite Metformin Therapy" @default.
- Q64723604 P17 Q213 @default.
- Q64723604 P17 Q30 @default.
- Q64723604 P17 Q33 @default.
- Q64723604 P17 Q34 @default.
- Q64723604 P17 Q41 @default.
- Q64723604 P17 Q664 @default.
- Q64723604 P17 Q668 @default.
- Q64723604 P17 Q801 @default.
- Q64723604 P17 Q96 @default.
- Q64723604 P2899 "+18" @default.
- Q64723604 P3098 "NCT00601250" @default.
- Q64723604 P31 Q30612 @default.
- Q64723604 P4135 "+80" @default.
- Q64723604 P4844 Q19484 @default.
- Q64723604 P4844 Q909745 @default.
- Q64723604 P580 "2008-01-01T00:00:00Z" @default.
- Q64723604 P582 "2009-05-01T00:00:00Z" @default.
- Q64723604 P6099 Q42824827 @default.
- Q64723604 P8363 Q78089383 @default.